Fusion of CTLA-4 with HPV16 E7 and E6 enhanced the potency of therapeutic HPV DNA vaccine. - Wikidata - awgldk - TriplyDB

Fusion of CTLA-4 with HPV16 E7 and E6 enhanced the potency of therapeutic HPV DNA vaccine.

Fusion of CTLA-4 with HPV16 E7 and E6 enhanced the potency of therapeutic HPV DNA vaccine.

http://www.wikidata.org/entity/Q34275134

about

Codon optimization of the human papillomavirus E7 oncogene induces a CD8+ T cell response to a cryptic epitope not harbored by wild-type E7 Trial watch: Naked and vectored DNA-based anticancer vaccines Construction of a fusion plasmid containing the PSCA gene and cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) and its anti-tumor effect in an animal model of prostate cancer.Therapeutic potential of an AcHERV-HPV L1 DNA vaccine.Tapping the Potential of DNA Delivery with Electroporation for Cancer Immunotherapy.Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases.Activities of stromal and immune cells in HPV-related cancers.

P2860

Q35208290-74973EB9-0AC1-4398-8034-11F743CAAA9F Q35798986-BD9A92B3-E293-4BFB-B291-6B5AFE0DA706 Q37384416-DEA17A4A-19FD-4B34-8E05-871C5C60E18B Q38869506-DBA109B4-A46C-49B9-BD66-ED76C6E4891B Q41435861-906EC4E4-AC85-452D-BCC7-0074C48D6344 Q50115667-875C46B2-7E63-4BD7-B3BF-80CBC692479A Q55507801-9887399E-3342-4A90-AEF2-23F2017AA23E

P2860

Fusion of CTLA-4 with HPV16 E7 and E6 enhanced the potency of therapeutic HPV DNA vaccine.

http://www.wikidata.org/entity/Q34275134

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Fusion of CTLA-4 with HPV16 E7 ...... f therapeutic HPV DNA vaccine.

@ast

Fusion of CTLA-4 with HPV16 E7 ...... f therapeutic HPV DNA vaccine.

@en

Fusion of CTLA-4 with HPV16 E7 ...... f therapeutic HPV DNA vaccine.

@nl

type

label

Fusion of CTLA-4 with HPV16 E7 ...... f therapeutic HPV DNA vaccine.

@ast

Fusion of CTLA-4 with HPV16 E7 ...... f therapeutic HPV DNA vaccine.

@en

Fusion of CTLA-4 with HPV16 E7 ...... f therapeutic HPV DNA vaccine.

@nl

prefLabel

Fusion of CTLA-4 with HPV16 E7 ...... f therapeutic HPV DNA vaccine.

@ast

Fusion of CTLA-4 with HPV16 E7 ...... f therapeutic HPV DNA vaccine.

@en

Fusion of CTLA-4 with HPV16 E7 ...... f therapeutic HPV DNA vaccine.

@nl

P1433

Q34275134-9D53BE8A-8136-4E5F-B581-F00FC9646F15

P1476

Q34275134-A2D8653F-43B0-468B-BCD0-CC605D796275

P2093

Q34275134-303CAD39-2152-41E8-B6D4-CA4DDCC48450

Q34275134-8DECF65D-A96F-48A2-A0DE-206317889297

Q34275134-AF71E9BA-CEBE-4BE7-B37A-9124C918B885

Q34275134-FB4C0F5D-CEB1-4C11-999A-F3902A13E4E8

P2860

Q34275134-0CF06B05-D64D-4A2F-87AD-2CB186C15AF5

Q34275134-10A9620F-D5A0-44D9-84D0-A77F5EA0E595

Q34275134-2726EC8F-AD84-4F0A-99AD-CEAA26951F59

Q34275134-31F6076E-C844-43F4-8844-CE416242D753

Q34275134-39F50B97-FD20-45F8-8643-7B9A04064866

Q34275134-3E2CD40B-2BB1-4148-9FE1-5297A5C0794D

Q34275134-41857EA4-9A8D-4B1F-9584-5325943FA2D6

Q34275134-4659297E-7982-47D2-AD13-EEF4B8FDD44D

Q34275134-48F37FA4-2B6A-4CE0-81CB-5905C05C7F71

Q34275134-49276C09-C43C-4E96-8793-97C012F1B5F7

P304

Q34275134-26521116-2EA6-4336-82D9-9CBA697FD8AB

P31

Q34275134-96977E6E-9BBD-4E34-A9D1-18E8B6DA0EDA

P356

Q34275134-DC72966A-6339-45EF-B55A-CA7569191199

P407

Q34275134-83CE9BE3-D30C-4D42-97AF-60A62231EC7F

P433

Q34275134-9F484253-9538-4845-9AF5-98C07FAD9154

P478

Q34275134-93630889-0125-4239-870C-E1518AD1C34E

P50

Q34275134-B8B7ACA7-DBFD-4E81-B992-2C8E5CCDA742

P577

Q34275134-CD6315A1-28CA-4471-A64A-6684985467E8

P5875

Q34275134-5125F099-6A8C-458C-A0FE-61166483F0B7

P698

Q34275134-62971CA6-AB31-4020-92E2-A572E8D6080A

P932

Q34275134-362EA9D4-A8B0-477E-8623-B2F2D86D5A06

P356

JOURNAL.PONE.0108892

P1433

P1476

Fusion of CTLA-4 with HPV16 E7 ...... f therapeutic HPV DNA vaccine.

@en

P2093

Lili Gan

http://www.w3.org/2001/XMLSchema#string

Lili Zhou

http://www.w3.org/2001/XMLSchema#string

Mingwen Fan

http://www.w3.org/2001/XMLSchema#string

Rong Jia

http://www.w3.org/2001/XMLSchema#string

P2860

Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins

Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males

CTLA-4 blockade in tumor models: an overview of preclinical and translational research

Improving the efficacy of antibody-based cancer therapies

Antibody therapy of cancer

Papillomaviruses and cancer: from basic studies to clinical application

DNA immunization with fusion of CTLA-4 to hepatitis B virus (HBV) core protein enhanced Th2 type responses and cleared HBV with an accelerated kinetic.

Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product.

Comprehensive control of human papillomavirus infections and related diseases

A phase I trial of a human papillomavirus DNA vaccine for HPV16+ cervical intraepithelial neoplasia 2/3.

P304

e108892

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0108892

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266325503

http://www.w3.org/2001/XMLSchema#string

P698

25265018

http://www.w3.org/2001/XMLSchema#string

P932

4181872

http://www.w3.org/2001/XMLSchema#string